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ABSTRACT
At the molecular level, members of the NKx2.2
family of transcription factors establish neural
compartment boundaries by repressing the expres-
sion of homeobox genes specific for adjacent
domains [Muhr et al. (2001) Cell, 104, 861–873;
Weiss et al. (1998) Genes Dev., 12, 3591–3602]. The
Drosophila homologue, vnd, interacts genetically
with the high-mobility group protein, Dichaete,i n
a manner suggesting co-operative activation [Zhao
and Skeath (2002) Development, 129, 1165–1174].
However, evidence for direct interactions and tran-
scriptional activation is lacking. Here, we present
molecular evidence for the interaction of Vnd and
Dichaete that leads to the activation of target gene
expression. Two-hybrid interaction assays indicate
that Dichaete binds the Vnd homeodomain, and
additional Vnd sequences stabilize this interaction.
In addition, Vnd has two activation domains that are
typically masked in the intact protein. Whether vnd
can activate or repress transcription is context-
dependent. Full-length Vnd, when expressed as a
Gal4 fusion protein, acts as a repressor containing
multiple repression domains. A divergent domain in
the N-terminus, not found in vertebrate Vnd-like
proteins, causes the strongest repression. The co-
repressor, Groucho, enhances Vnd repression, and
these two proteins physically interact. The data pre-
sented indicate that the activation and repression
domains of Vnd are complex, and whether Vnd
functions as a transcriptional repressor or activ-
ator depends on both intra- and inter-molecular
interactions.
INTRODUCTION
Homeobox genes play essential instructional roles in many
developmental processes, including patterning the early
embryo and specifying embryonic cell lineages. The NK-
type homeobox genes encode transcription factors with a
divergent homeodomain and two additional highly conserved
domains,thecandidateGroucho interactiondomain referred to
as the NK decapeptide or Engrailed homology (EH) domain,
and the NK-2 box or the NK-2 speciﬁc domain (1–3). The
Drosophila NK-2 homeobox gene, vnd, speciﬁes ventral
neuroblast identity (4,5). This dorsal–ventral patterning gene
represses the expression of the homeobox gene, intermediate
neuroblast identity (ind), which is expressed in neuroecto-
dermal cells adjacent to the bilateral columns of vnd expres-
sing ventral cells. Three vnd binding sites in the ind enhancer
mediate this repression (6).
The question of whether Vnd can directly activate tran-
scription has not been addressed, despite the fact that vari-
ous potential target genes are not activated in vnd mutants.
These include the proneural genes, achaete and scute, the
homeobox gene, Nk6 and the zinc ﬁnger transcription factor,
Escargot. vnd also autoactivates its own expression (7–9). In
addition, epistasis tests and double mutant analyses suggest
that Vnd and the high-mobility group (HMG) proteins,
Dichaete and Sox Neuro, co-operate to regulate patterning
and cell fate decisions in the Drosophila neuroectoderm
(10,11). NKx2.2, the closest vertebrate homologue of vnd,
is also required for dorsal–ventral patterning of the ventral
neural tube, as well as pancreatic speciﬁcation (12–14).
Within the neural tube, NKx2.2 interacts with the co-
repressor, Groucho, to repress inappropriate expression of
target genes (1). Groucho lacks a DNA-binding domain
(DBD), but regulates transcription by interacting with
DNA-binding transcription factors to form a repression
complex [for review see (15)].
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doi:10.1093/nar/gki140Vnd is a 723 amino acids protein (3,16) that is signiﬁ-
cantly larger than its vertebrate counterparts, such as
NKx2.2. This Drosophila protein is likely to be complex,
as it may perform functions that are executed by the mul-
tiple vertebrate NKx2 family members. In this report, we
dissected the domains of the Vnd protein using a hetero-
logous system in transient transfection assays. If Vnd reg-
ulatory domains can function in a heterologous context with
a DBD from another transcription factor, that domain con-
tains sufﬁcient sequence information to execute a speciﬁc
regulatory function. These domain swap experiments iden-
tiﬁed multiple repression domains in Vnd. We found that
the conserved homeodomain and NK-2 box have signiﬁcant
repressor activity when expressed in conjunction with other
Vnd sequences. We also uncovered two activation domains
that are masked by the repressor activity of the intact Vnd
protein in cell culture. In immunoprecipitation and mamma-
lian two-hybrid interaction assays, we found that Vnd phys-
ically interacts with the high-mobility Sox activator,
Dichaete, through the homeodomain. While Vnd had little
effect on its own enhancer, co-expression with Dichaete
enhances its activation capacity co-operatively in transient
transfections. Likewise, under similar assay conditions
Vnd requires the co-repressor, Groucho, to repress the ind
enhancer, through which Vnd represses ind expression in
embryos. These data are the ﬁrst biochemical evidence for
Vnd-dependent activation, and suggest that Vnd-mediated
activation or repression depends to a large extent on the
availability of co-factors.
MATERIALS AND METHODS
Tissue culture expression and reporter vectors
A 2.44 kb fragment corresponding to the Vnd open reading
frame (ORF), plus 10 bp 50 and 257 bp 30 of the ORF, was
cloned into the EcoR1 site of the pCMV-ﬂag vector (Sigma)
for expression in mammalian cells. CMV-ﬂag-groucho
4 (CMV-grg4) was kindly provided by Greg Dressler
(Department of Pathology, University of Michigan, Ann
Arbor, MI). A 2.5 kb EcoR1–BamH1 fragment corresponding
to one of the vnd enhancers was isolated from a P1 library and
subcloned into the Kpn1–BglII site of the pGL3 promoter
vector (Promega), following the addition of linkers. A 600 bp
fragment corresponding to a dimer of the ind enhancer
element, to which Vnd binds (6), was also cloned into
pGL3. The pFox Luc1-7xNK2 vector that contains seven
NKx2.2 consensus-binding sites upstream of the luciferase
gene was provided by Michael German (Department of
Medicine, University of California at San Fransisco, CA).
A 1 kb Pvu11–XbaI fragment, lacking sequences encoding
the ﬁrst 30 amino acids of Dichaete, was cloned into the
Not1 site of pACT (Promega) and of pCMV-ﬂag, following
ﬁll in with Klenow. John Nambu (Biology Department,
University of Massachusetts at Amerherst, Amerherst, MA)
kindly gave us the Dichaete cDNA. The pACT vector encodes
the VP16 activation domain.
Tissue culture Gal4 fusion constructs
For the generation of Gal4–Vnd fusion constructs, relevant
vnd cDNA fragments were subcloned into pBind vector
(Promega), which encodes the Gal4 DBD (amino acids 1–147)
driven by the cytomegalovirus (CMV) promoter and enhancer,
using appropriate restriction enzymes and Klenow fragments
(see Table 1). pBind also encodes Renilla luciferase under
the control of the SV40 early enhancer and promoter.
To express the NK decapeptide and the NK-2 box as Gal4
chimeras, complimentary oligonucleotides were used. The
sequence of the positive-strand oligonucleotide for the NK
decapeptide is: 50-GGCTTCCATATATCGGACATCTTGA-
ATTTGGAGGGCTCTGAGCTGAAGAATGCAGCAGC-30.
The sequence of the NK-2 box oligonucleotide is:
50-CATCGCCCCGTCGGGTAGCCGTTCCAGTTCTGGTGA-
GGAACGGAAAGCCCTGCTTGGGCGATAGTTCCAAA-
CTGGGAGCCG-30. Complimentary oligonucleotides were
kinase-treated, denatured, annealed and cloned into pBind.
Each construct was sequenced using vector-speciﬁc primers.
Cell culture, transfections, one- and two-hybrid
cell culture assays, and luciferase assays
293 cells were plated at 500000 cells/ml into 6-well plates,
cultured in DMEM + 10% fetal calf serum (FCS) containing
1% penicillin/streptomycin at 37 C, and transfected the
following day with Fugene-6 (Roche), according to the man-
ufacturer’s instructions. The volume of Fugene-6 used was
twice that of the DNA. pBind (Promega) encodes Renilla
luciferase, which was used to monitor transfection efﬁciency.
The pG5luc reporter (Promega) encodes ﬁreﬂy luciferase
downstream of ﬁve Gal4-binding sites. For the chimeric
one-hybrid assays, 1.5 mg of DNA was transfected and the
molar ratio of the expression vector to the reporter vector
was 2:1. For the co-transfection of pCMV-ﬂag-groucho 4 and
pCMV-ﬂag-dichaete with the pBind-vnd and pCMV-vnd con-
structs, the ratio of pBind to pG5luc was 2:1. pGem-3Z was
added to maintain the amount of DNA transfected constant.
Forthe two-hybrid assay, the molar ratioofthe pACT topBind
to pG5Luc constructs was 1:1:1, and 2.5 mg of DNA was used
per transfection. The Checkmate Two Hybrid kit (Promega)
was used according to the manufacturer’s instructions.
Forty-eight hours after transfection, cells were washed
with phosphate-buffered saline (PBS), scraped into passive
lysis buffer (Promega) and rocked for 15 min gently at
Table 1. Restriction sites used to generate pBind-constructs
Construct name Encodes amino acids Restriction sites
A1 3–717 Asp1–Bgl1
A2 3–613 Asp1–Acc1
A3 3–519 Asp1–EcoRV
A4 3–406 Asp1–Kpn1
A5 3–217 Asp1–Pvu11
A6 3–197 Asp1–BstX1
A7 217–717 Pvu11–Bgl1
A8 406–717 Kpn1–Bgl1
A9 519–717 EcoRV–Bgl1
A10 613–717 Acc1–Bgl1
A11 657–717 Asp1–Bgl1
A13 217–519 Pvu11–EcoRV
A14 217–406 Pvu11–Kpn1
A15 406–519 Kpn1–EcoRV
A16 535–613 BamH1–Acc1
A17 535–616 BamH1–Acl1
A18 566–613 Acl1–Acc1
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lysate was assayed for Renilla and ﬁreﬂy luciferase activity
using the Dual Luciferase Kit (Promega), according to
the manufacturer’s instructions. Note that the pBind vector
encodes the Renilla luciferase, while the pG5luc vector
encodesthe ﬁreﬂy luciferase.Eachtransfection wasperformed
atleast threetimes. DrosophilaS2cells were maintainedatRT
in M3 media containing 10% FCS and 1% penicillin/strepto-
mycin, and were otherwise handled similar to the 293 cells.
Co-immunoprecipitation and western analyses
from tissue culture cells
4.5 mg of pBind-vnd or empty pBind, 1.5 mg of pCMV-ﬂag-
grg4 or pCMV-ﬂag-dichaete or empty vector, and 1.6 mgo f
pGL3-vnd or pGL3-ind were transfected into 100 mm dishes
containing 293 cells. Forty-eight hours after transfection, cells
were washed with PBS, scraped and the supernatant removed
following centrifugation. Cells were resuspended in immuno-
precipitation (IP) buffer [20 mM Tris–HCl, 100 mM NaCl,
10 mM NaF, 1 mM Na3VPO4, 1 mM phenylmethylsulfonyl
ﬂuoride (PMSF) and protease inhibitor cocktail (Roche)
containing 0.5% Triton X-100] and brieﬂy vortexed.
Non-speciﬁc binding proteins were removed by pre-
incubating the supernatant with protein A/G PLUS agarose
(Santa Cruz Biotechnology) for 30 min at 4 C, and then
removing them by centrifugation. Cell lysates were then
incubated with M2 anti-Flag antibody (Sigma), and rotated
overnightat4 C,followingincubationwithproteinA/G PLUS
agarose,androtation at4 Cfor2h.Beads were precipitatedby
centrifugation, and washed three times with IP buffer contain-
ing 0.1% Triton X-100. Then, beads were resuspended in
SDS–PAGE sample buffer. Immunoprecipitates were
separated by SDS–PAGE electrophoresis, transferred onto
Immobilon-P (Millipore) membrane, and western blotted. Du-
plicate blots were incubated with anti-Flag antibody (Sigma)
to detect the Flag-tagged Groucho 4 and Dichaete proteins, or
a Gal4-speciﬁc antibody (Santa Cruz Biotechnology)
to detect Gal4–Vnd chimeric protein. Binding of peroxi-
dase-conjugated secondary antibodies was detected by chemi-
luminescence, using the Lightning kit (Perkin Elmer).
Yeast constructs, in vitro transcription and translation,
and related immunoprecipitations
Asp1–Bgl1, Asp1–EcoRV and Kpn1–Bgl1 vnd cDNA frag-
ments (Table 1) were PCR-ampliﬁed using a 50 primer with an
EcoR1 site added, and a 30 primer with a Sal1 site added, and
clonedintothebaitvector,pGBKT7(Clontech).PCRproducts
encoding the ORFs of Dichaete and ﬂy groucho, containing
synthetic 50 EcoR1 and 30 Xho1 sites, were also cloned into the
pGADT7 prey vector (Clontech). Sequencing was used to
conﬁrm the identity of the PCR products, and that the indi-
vidual fragments had been cloned in frame. Using the T7
promoter, located upstream of the myc tag in pGBKT7, and
the hemagglutinin (HA) tag in pGADT7, individual prey and
bait proteins were in vitro transcribed and translated using
the TNT T7 Coupled Reticulocyte Lysate kit (Promega)
with
35S-labeled methionine, according to the manufacturer’s
instructions. Immunoprecipitations were performed using the
HA antibody from the Matchmaker Co-Immunoprecipatation
kit (Clontech), according to the manufacturer’s instructions.
Following separation by SDS–PAGE, labeled proteins in the
in vitro transcription–translation reactions and the co-immu-
noprecipitations were identiﬁed using autoradiography.
RESULTS
Transient expression of Vnd in Drosophila S2 or vertebrate
293 cells had minimal effects on reporter gene activation or
repression, using three different candidate targets, despite
strong Vnd expression in both cell types. The candidate target
sequences tested were as follows: the vnd enhancer that directs
vnd-speciﬁc expression from stage 6 onwards (17), the repres-
sion element previously identiﬁed inthe ind enhancer (6) and a
concatenate of seven binding sites corresponding to the con-
sensus NKx2.2 recognition motif (18) (data not shown).
Watada et al. (18) similarly found that intact Nkx2.2 had
minimal effects on reporter expression driven by seven con-
sensus Nkx2.2 binding sites. To facilitate the identiﬁcation of
the functionally important domains in Vnd, we used a one-
hybrid assay in which Vnd was fused to the DBD of Gal4.
Using this assay, we were able to delineate different Vnd
domains and test their efﬁcacy on reporter gene activation
or repression using a Gal4-speciﬁc reporter construct
(Figure 1).
Identification of activation and repression
domains in Vnd
Full-length Vnd fused to the Gal4 DBD represses ﬁreﬂy
luciferase reporter expression 7- to 8-fold (construct A1,
Figure 1C), consistent with its potential role as a repressor
in the developing nervous system. To delineate the repression
domain more precisely, we made C- and N-terminal dele-
tions of Vnd and fused these to the Gal4-DBD. Deletion of
100 amino acids at the C-terminal of Vnd, including the con-
served NK-2 box (construct A2, Figure 1C), leads to a slight,
but reproducible, 10% increase in repression activity, relative
to A1. Further deletions encompassing the homeodomain
(construct A3, Figure 1C) cause a 75% decrease in repressor
activity relative to full-length Vnd. However, repressor activ-
ity is restored to the level of full-length Vnd if additional
sequences are deleted to amino acid 217 (constructs A4 and
A5, Figure 1C). These results suggest that sequences spanning
amino acids 217–406 likely have de-repression or activator
function. The ﬁrst 217 amino acids of Vnd (construct A5,
Figure 1C) include the NK decapeptide or the EH domain
(1,2).Surprisingly,whenthe NKdecapeptide isremoved (con-
struct A6, Figure 1C), the repression activity of the chimera is
not greatly affected. Thus, C-terminal deletions of Gal4–Vnd
chimeras uncover multiple redundant repression domains.
To conﬁrm and extend our observations, we also analyzed
N-terminal deletions (Figure 1D). Deletion of amino acids
3–217 signiﬁcantly reduces repressor activity (construct A7,
Figure 1D), consistent with the activity of constructs A5 and
A6. Further N-terminal deletion to amino acid 519 increases
repressor activity (constructs A8 and A9, Figure 1D), although
not quite to the full-length Vnd levels. Again, these results are
consistent with the homeodomain having repressor function.
The C-terminal 60 amino acids are able to activate reporter
gene expression, consistent with the slight increase in repres-
sion observed upon deletion of this sequence in A2
Nucleic Acids Research, 2005, Vol. 33, No. 1 3Figure 1. Structure–function analysis of Vnd–Gal4 fusion proteins. (A) Schematic representation of the Vnd ORF from amino acids 1 to 722. Salient features
depictedare:theNKdecapeptide,blackbox;thehomeodomain,openbox;andtheNK-2box,solidgraybox,aswellastherelevantaminoacidsspanningthedifferent
domains. (B) Schematic representation of the luciferase reporter gene driven by five Gal4-binding sites upstream of the adenoviral late promoter. (C) C-terminal
deletionsofVndfusedtotheGal4-DBDareshownschematically.Thelevelsofluciferaseactivationorrepressionareshownnormalized.Atypicalbaselinereading
forRenillaluciferase(R)was6200,andfireflyluciferase(F)was12.9.TheF/Rvaluewassetat1-fold.Allconstructsbeginataminoacid3andextendtotheindicated
C-terminalresidues.(D)N-terminaldeletionsofVndfusedtotheGal4-DBDareshownwithrelativeluciferasevaluesasdescribedin(C).Transfectionsweredonein
triplicate with average levels of activation or repression shown. The error bars are 1 SD from the mean.
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indicate that the sequences spanning the homeodomain
and NK-2 box, and the sequences spanning 3–217, are able
to independently repress activation. However, the region
spanning 217–519 can function to de-repress these domains
individually. In the presence of both repressor domains, the
effect of the depression region is minimal.
To assess the potential of the candidate regulatory domains
to function independently, we assayed the activity of
constructs encoding speciﬁc internal Vnd regions that were
delineated by the N- and C-terminal deletions. Surprisingly,
we found that the capacity of the EH domain, the homeo-
domain and the NK-2 box to repress transcription is minimal,
whenexpressedindependentofotherVndsequences(Figure2,
constructs A12, A16–A19, respectively). Assuming that steric
hindrance does not account for these observations, these
results suggest that these domains interact with one another,
or other Vnd sequences, in the intact protein to repress
transcription. More signiﬁcantly, a strong activation domain
was found that maps onto the amino acids 217–406 (construct
A14, Figure 2). Again, this is consistent with the de-repression
activity observed in the previous deletions. No difference in
luciferase levels was seen when Vnd was expressed independ-
ent of the Gal4-DBD with the empty pBind vector, which
indicates that the Vnd-dependent effects seen are not due to
Vnd activity in a target DNA-independent manner. Thus, Vnd
has two activation domains, spanning 217–406 and 657–717,
which are typically masked in the intact protein, suggesting
that Vnd can function as an activator under the appropriate
circumstances. For each of the constructs generated in
Figures 1 and 2, western blotting with an antibody against
the Gal4-DBD generated the expected sized protein at levels
consistent with the efﬁciency of transfection (data not shown).
Furthermore, all of the Vnd chimeric proteins were found in
the nucleus of transfected cells when the same antibody was
used for immunostaining (data not shown).
Interaction of Vnd with co-factors
For transcriptional activation, co-activators are typically
required in addition to the general transcription factors needed
for basal transcription. Recent genetic analyses suggest that
the HMG proteins, Dichaete and Sox neuro interact with Vnd
(10,11). Zhao and Skeath (12) found that the frequency of loss
of marker expression in two ventral neuroblasts was increased
in vnd, Dichaete double mutants relative to that seen in either
vnd or Dichaete single mutants. Because HMG proteins bend
DNA to align non-contiguous DBDs for interaction with other
transcription regulators and physically interact with other
regulatory proteins to activate transcription (19–23), we
asked whether Vnd physically interacts with Dichaete by
doing a two-hybrid interaction assay in mammalian cells
usingtheCheckmateKit(Promega).Weintroduced achimeric
plasmid, pACT-Dichaete, which encodes the VP16 activation
domain in frame with the Dichaete ORF into the one-hybrid
assay. We found that when increasing concentrations of
VP16–Dichaete are co-expressed with Gal4–Vnd, the repres-
sion of baseline luciferase activity caused by the full-length
Vnd–Gal4 chimera was signiﬁcantly reduced. When Dichaete
was expressed at a 4-fold molar excess relative to Vnd,
repression was reduced  6-fold (Figure 3, A1).
Figure 2. Analysis of separate Vnd domains fused to the Gal4-DBD. Fusion proteins containing the indicated Vnd amino acids fused to Gal4-DBD are shown
schematically. The level of activation or repression is shown relative to the Gal4-DBD alone, which has an assigned value of 1. Note the delineation of a strong
activation domain spanning amino acids 217–406 with construct A14.
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interact with Dichaete, using our series of Gal4–vnd deletion
constructs. There was a 3- to 3.5-fold alleviation of repression
when a Gal4–Vnd chimera encoding the N-terminal of Vnd,
including the homeodomain (Figure 3, amino acids 3–613,
A2), was co-expressed with VP16–Dichaete, relative to
empty pBind plus pACT-Dichaete. Excluding the homeo-
domain in the N-terminal construct (Figure 3, amino acids
3–519, A3) leads to only very slight alleviation of repression,
which suggests that the Vnd homeodomain is important for
Dichaete interaction; whereas, expression of the C-terminal
amino acids 519–717, including the homeodomain (Figure 3,
A9), resulted in an 8- to 9-fold alleviation of repression. This
indicates that Vnd sequences in this region must interact with
Dichaete strongly. To further deﬁne the Dichaete interaction
domain in the C-terminal region of vnd, we expressed the Vnd
homeodomain and the downstream region, independent of
each other, as Gal4 chimeras. When expressed in conjunction
with VP16–Dichaete, neither peptide activated luciferase
activity signiﬁcantly, compared to when the domains were
expressed together (Figure 3, A10 and A16). Although we
cannot rule out steric hindrance accounting for the inability
of the smaller Vnd sequences to interact with Dichaete, these
results suggest that the homeodomain is necessary, but not
sufﬁcient, for binding of Vnd to Dichaete. The C-terminal
sequences downstream of the homeodomain may facilitate
Dichaete binding. In agreement with these observations, the
homeodomains of Bicoid, and Oct-type homeodmain proteins
has been implicated in the interaction of these transcription
factors with other HMG proteins (24–26).
Dichaete interacts with the CNS-midline-speciﬁc proteins,
Single-minded and Tango, to activate ventral midline Slit
gene expression (23). A 2.5 kb region of the vnd enhancer
directs ventral cord expression (17,27). We examined
this region for the presence of consensus Dichaete-binding
sites [AACAAT and AACAAAG (22)] and Vnd-binding
Figure 3. Interaction of Vnd with the high-mobility protein, Dichaete, relieves Vnd–Gal4-mediated repression. The indicated Vnd–Gal4 fusion proteins were
expressed transiently with increasing amounts of a pACT-Dichaete expression plasmid. Expression of the VP16 activation domain fused to Dichaete from this
constructrelievesVnd–Gal4-mediatedrepressionoftheluciferasereporterbecauseofVnd–Dichaeteinteractions.Thebaselineforeachexperimentalserieswasset
using pACT-Dichaete with empty pBind. Because the Vnd domains have regulatory activity in the one-hybrid assay, the data are expressed as fold de-repression.
Note that full de-repression of Vnd–Gal4 by Dichaete requires the presence of the homeodomain and sequences C-terminal to this domain.
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Dichaete-binding sites are present at positions 350 and
1350, independent of three candidate Vnd-binding sites that
have six out of seven of the consensus nucleotides at positions
50, 700 and 1020, respectively. We hypothesized that if
Dichaete interacts with Vnd physically, this could cause
bending of the vnd enhancer, so that the non-adjacent binding
sites for Vnd and Dichaete are juxtaposed. This modulation of
target DNA availability, combined with the likely conforma-
tional changes in Vnd resulting from its interaction with
Dichaete, could potentially lead to the activation of reporter
expression.
When we addressed this possibility initially in S2 cells, we
found that although Vnd is strongly expressed in these cells
under the control of the actin promoter, the effects on reporter
expression driven by the vnd enhancer are negligible.
Dichaete, when expressed alone caused weak activation of
reporter expression, whereas co-expression of Dichaete and
Vnd lead to enhancer activation at levels greater than
when Dichaete was expressed on its own (data not shown).
We repeated the experiment in 293 cells, using the CMV
promoter to drive protein expression (Figure 4). With increas-
ing concentrations of pCMV-Dichaete, luciferase expression
driven by the vnd enhancer was increased to a maximum level
of 150% [when the baseline was set at 0 (Figure 4, B)],
whereas increasing the concentration of pCMV-vnd lead to
a slight reduction in luciferase expression (Figure 4, A).
However, when Vnd and Dichaete were co-expressed, reporter
expression was activated to a maximum level of 250%
(Figure 4, C), relative to the baseline level of reporter expres-
sion. Because the sum of the effects of Vnd and Dichaete
expressed together is signiﬁcantly greater than when each
transcription factor is expressed independently, our results
suggest that these two regulators co-operate with the vnd
enhancer to activate reporter expression. The capacity of
Vnd to activate is target gene dependent. Dichaete did not
affect Vnd activity when co-expressed in cells in the presence
of a reporter driven by the ind enhancer, through which Vnd
mediates repression in the embryo (6).
Groucho enhances Vnd repression
We also asked whether exogenous Groucho affects the capa-
city of intact Vnd to repress luciferase reporter expression,
because Vnd has an NK decapeptide or EH domain. In addi-
tion, there are AT-rich domains in close proximity to the
binding sites for Vnd in the ind enhancer (6). Groucho repres-
sion complexes typically bind these AT-rich domains when
appropriately positioned (28). When we used the ind enhancer
to direct luciferase reporter expression, luciferase activity was
only very slightly repressed when Vnd was expressed alone.
The repression was variable and the maximum level seen was
a bare 15% decrease in luciferase activity (Figure 4, D). Like-
wise, when Grg4 was expressed alone, it had minimal effects
on luciferase activity (Figure 4, E). However, when Vnd
and Grg4 were co-expressed, repression of luciferase activity
Figure4.EffectsofDichaeteandGrouchoonVndregulatoryactivity.Cellsweretransientlytransfectedwiththeplasmidsindicated.Thereporterplasmidcontained
the vnd promoter fused to the luciferase reporter gene (pGL3-vnd)o ra nind enhancer (pGL3-ind). The baseline firefly/Renilla luciferase reading was  3. Vnd
expressionalonehadnegligibleeffectsonbothreporters(AandD).ExpressionofDichaetealonewasabletoactivatethevndpromoter 1-fold,a100%increase(B).
Co-expressionofDichaetewithVndincreasedthelevelofactivationto>2.5-foldto250%activationabovebackground(C),suggestingco-operation.Expressionof
increasing amounts of the Groucho protein, Grg4, had no effect on reporter expression (E); whereas pGL3-ind reporter expression was suppressed by >50% when
Grg4 and Vnd were co-expressed (F).
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(Figure 4, F). Again, Vnd’s capacity to co-operate with
Groucho in repressing gene expression was target-dependent,
and required the ind enhancer. Co-expression of Vnd and
Groucho in the presence of the vnd enhancer had no effect
(data not shown). These combined results indicate that both
co-factor availability and target DNA accessibility inﬂuence
Vnd’s capacity to activate and repress transcription.
Vnd can co-precipitate with both Dichaete
and Groucho
Our data suggest that Vnd interacts directly with the co-
activator, Dichaete, and the co-repressor, Groucho, and this
interaction leads to either target activation or repression. To
conﬁrm this, we performed co-precipitation analyses. Because
our Vnd antibody was relatively ineffective for western-blot
analyses, we conﬁrmed that the expression of Vnd fused to the
Gal4-DBD with Flag-tagged Groucho or Dichaete resulted in
enhanced repression and activation of vnd targets, similar to
intact Vnd without an additional tag (see Figure 4; data not
shown). When we immunoprecipitated Flag-tagged Dichaete
or Grg4 from cell lysates using a Flag antibody, Gal4-tagged
Vnd was pulled down with both co-regulators. These results
indicate that Dichaete and Grg4 physically interact with Vnd
(Figure 5).
We further examined the physical interactions of Groucho
and Dichaete with Vnd by addressing whether these co-factors
interact in a yeast two-hybrid assay using the Matchmaker Gal
4 Two Hybrid System 3 kit (Clontech). We cloned full-length
vnd into the bait vector, pGBKT7, as well as two smaller vnd
domains. Because of concerns about steric interference that
arose in the Vnd–Gal4 chimeric assays, we selected the A3
and A8 Vnd constructs for the yeast assays. A3 lacks the
homeodomain and its C-terminal sequences, but includes
the EH domain, whereas A8 extends from amino acid 406,
and includes the homeodomain and Nk-2 box. Full-length ﬂy
groucho and Dichaete were also cloned into the pGADT7 prey
vector. AH109 cells were transformed with the various
constructs. Because all the three bait proteins drove alpha
gal expression without an interacting protein, we monitored
prey–bait interactions by measuring growth on HIS
 
medium. We found that both Dichaete and Groucho interacted
with full-length Vnd very poorly in this assay. When the
Figure 5. Vnd physically interacts with the co-activator, Dichaete, and the co-repressor, Groucho. Western blots of cell lysates (A and C) following transient
transfections,andcorrespondingimmunoprecipitates(BandD)incubatedwithananti-Flagantibody(AandB)andanti-Gal4antibody(CandD).Lanescorrespond
to transfections: Lane 1, pBind-vnd, pGL3-vnd and pCMV-flag; lane 2, pCMV-flag-Dichaete, pGL3-vnd and pBind; lane 3, pBind-vnd, pCMV-flag-Dichaete and
pGL3-vnd; lane 4, pCMV-flag-grg4, pGL3-ind and pBind; and lane 5, pBind-vnd, pCMV-flag-grg4 and pGL3-ind. In the cell lysates shown in (A), bands
corresponding to Flag-tagged Dichaete and Groucho 4 proteins, with predicted molecular weights of 45 and 88 kDa are seen. In (C), the Gal4 antibody
recognizes the Gal4–Vnd chimera (black arrowhead), with a predicted molecular weight of 90 kDa. (B) Western blot of immunoprecipitates generated using
the anti-Flag antibody, which immunoprecipitates Dichaete and Grg4. (D) Vnd (black arrowhead) is pulled down when co-expressed with Dichaete, or Groucho 4.
Thus, Vnd physically interacts with these co-regulators.
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 , LEU
 , TRP
  medium
with concentrations of 3-AT ranging from 0 to 15 mM, it took
5 days at 30 C for small colonies to grow, relative to unrelated
controls that grew well after 3 days. Transformants encoding
Groucho and the A3 Vnd deletion mutant failed to activate
HIS
  expression, while transformants encoding the A8 Vnd
deletion mutant and Dichaete grew well on HIS
 , LEU
 ,
TRY
  medium containing 10 mM 3-AT after 3 days at
30 C (data not shown).
Since these observations question our ﬁnding that Vnd can
co-precipitate with both Dichaete and Grg 4, we tested
whether the bait and prey proteins interact in co-precipitations
assays. Using the Matchmaker Co-IP kit (Clontech) and the
TNT T7 Coupled Reticulocyte Lysate System (Promega), we
made
35S-labeled A1, A3 and A8 Vnd from the bait plasmids
in vitro, with N-terminal Myc-tags (but lack the Gal4-DBD;
Figure 6, lanes 1–3). Similarly, we made
35S-labeled Groucho
and Dichaete from the T7 prey plasmids, which have a HA tag
(but lack the Gal4 activation domain; Figure 6, lanes 4 and 5).
The HA antibody proved more effective than the Myc anti-
body in immunoprecipitations (data not shown). Figure 6
(lanes 6–9) shows the results of pull downs with the HA
antibody. Conﬁrming our results from the co-immunoprecipi-
tations from tissue culture cells, we found that either HA-
tagged Dichaete or Groucho can pull down full-length Vnd
(Figure 6, lanes 6 and 8, respectively). Vnd lacking the ﬁrst
408 amino acids (A8) interacted with Dichaete (Figure 6,
lane 7), but the amount precipitated was less than when
full-length Vnd was co-precipitated (Figure 6, lane 6). We
were surprised to ﬁnd that the Vnd deletion mutant, A3,
which contains the EH domain but lacks N-terminal sequences
including the homeodomain and the NK-2 box, failed to
interact with Groucho (Figure 6, lane 9) in three independent
experiments. These results indicate that sequences in the
C-terminal region of Vnd are required for Groucho binding
to the EH domain, and potentially explain why we were unable
to assign repressor function to the EH domain in the Gal4–Vnd
chimera dissection assays. In agreement with these ﬁndings,
Winnier et al. (29) reported that in Caenorhabditis elegans
mutant Unc-4 failed to interact with Unc-37, the worm
Groucho, in two-hybrid interaction assays, and did not exhibit
in vivo repressor activity when the EH1 domain was intact,
but sequences N-terminal to the domain are missing.
DISCUSSION
Our dissection of the Vnd homeodomain protein in cell culture
suggests that this transcription factor is a complex combina-
tion of repression and activation domains. Both intra- and
inter-molecular interactions are apparently involved in the
DNA binding, activation and repression activity of Vnd. Chi-
meric analyses of Vnd subdomains indicate that there are at
least three repression domains and two activation domains that
can contribute to the regulatory capacity of this protein. These
activation and repression domains likely interact in the intact
protein to generate different patterns of regulation. Our ana-
lyses indicate that the co-repressor, Groucho, promotes the
repressional activity of Vnd, whereas interaction with the tran-
scriptional activator and DNA bending protein, Dichaete,
leads to target activation. Figure 7 summarizes our current
model for Vnd regulation of target gene expression that is
based on the data presented.
The Vnd homeodomain plays a complex role in the function
of this protein. Although capable of binding its target
in vitro (3,6,30), the homeodomain apparently does so very
Figure6.GrouchodoesnotbindaVnddeletionthatincludestheEHdomain,butlackstheC-terminalregionoftheprotein,whichincludesthehomeodomainandthe
Nk-2box.Left top:Schematicdiagramshowingthe Vnd proteincontainingthe NK decapeptide(blackbox), thehomeodomain(openbox)and theNK-2box (solid
light gray box), as well as the relevant amino acids spanning the different domains.Left bottom: Constructs A1, A3 and A8 that were used for immunoprecipitation
analyses. The dark gray box at the N-terminus depicts the myc tag. Lanes 1–5: S-35 distribution in rabbit reticulocyte lysates following in vitro transcription–
translationofA1,A3andA8,aswellasDichaete(D)andgroucho(gro).ArrowsindicatebandscorrespondingtotheindividualproteinsLanes6–9:S-35distribution
inimmunoprecipitatesfromamixtureofrabbitreticulocytelysatesofHA-taggedDorgrowiththeVndpeptides,followingimmunoprecipitationwithaHAantibody.
Lane6:DandA1.Bandsof 100and35kDa(arrows),correspondingtoA1andD,respectively.Lane7:DandA3.Bandsof 45and35kDa(arrows),corresponding
to A4 and D, respectively. Lane 8: gro and A1. A doublet at  90–100 kDa is seen (arrows), corresponding to A1 and gro, respectively. Lane 9: a single band at
 90 kDa is seen (arrow) corresponding to HA-tagged gro. However, A3 is not pulled down by gro. The gray arrowhead indicates the expected position of the Vnd
peptide.
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sient transfection assays. Watada et al. (18) showed that
removal of the C-terminal of NKx2.2 downstream of the
homeodomain leads to NKx2.2-activating reporter expression
in tissue culture, although the intact protein was unable to do
so. Co-factors are potentially required to stabilize the binding
of the homeodomain to its target in the context of the complete
protein. NMR analyses indicate that the conformation of the
Vnd homeodomainisaltered upon binding totarget DNA (30).
This potentially results in the protein surfaces available for
contact with the transcriptional machinery, and with other
regulatory proteins being altered. These intra-molecular
interactions would then provide a mechanism for transducing
information from the DBD to the other regulatory domains
within the protein. Our deletion analyses of Vnd–Gal4 chi-
meras in transient transfection assays suggest that the homeo-
domain interacts with repression domains at the N-terminal of
the protein. In keeping with this speculation, we found that
Groucho did not interact with a Vnd deletion, lacking the
N-terminal 200 amino acids including the homeodomain
and the NK-2 box, despite the presence of the EH domain
(Figure 6). Paradoxically, the homeodomain and sequences on
its C-terminal side are also required for the interaction of Vnd
with the transcription activator and DNA bending protein,
Figure 7. Summary of the regulatory domains in Vnd, and the mechanism of Vnd-mediated target gene regulation. (A) Schematic representation of the Vnd ORF
showingtheNKdecapeptide(blackbox),thehomeodomain(openbox)andtheNK-2box(solidgraybox).Below,therepressiondomainsweidentifiedaredepicted
inblack,whiletheactivationdomainsaredepictedingray.ThehomeodomainandtheNK-2boxrepresstranscription,whenexpressedasGal4–DBDchimerasinthe
contextofotherVndsequences,buthaveverylittleactivitywhenexpressedalone.TheNKdecapeptidehasverylittlerepressoractivityintransienttransfections.The
first 197 amino acids strongly repress transcription. We identified a strong activation domain on the C-terminal side of the NK decapeptide (amino acids 217–406),
andaweakeroneattheC-terminalendoftheprotein(aminoacids657–717).(B)The300bpindenhancerthroughwhichVndmediatesrepressionisshown,andthe
three Vnd-binding sites within 50 bp [B1; (2)]. Adjacent to the Vnd-biding sites are AT-rich sequences, to which Groucho-interacting co-repressors bind in other
enhancers (26). Vnd recruits Groucho, which does not directly bind DNA (B2). Groucho recruits its co-repressor complex, and this results in transcriptional
repression(B3).(C)The2.5kbvndenhancerisdepicted(27).TheexactbindingsitesofVndandDichaete,althoughnotfunctionallymapped,areschematized(C1).
Once Vnd and Dichaete bind their respective sites (C2), and physically interact with each other (C3), this causes DNA bending because the sites are not directly
adjacent to each other, and Dichaete has DNA bending activity. This combined effect of protein–protein interaction and DNA bending leads to reporter activation.
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interact with HMG proteins through their homeodomains
(24–26). Taken together, these results suggest that conforma-
tional changes in the native protein, including local protein
folding, play important roles in the capacity of Vnd to regulate
gene expression.
Extending the ﬁndings of Xhao and Skeath (11), we show
that Vnd’s interaction with the high-mobility Sox protein,
Dichaete, confers weak activation capacity on this homeo-
domain protein in transient transfections. Although Dichaete
co-operated with Vnd to activate reporter expression driven by
a vnd enhancer containing both Dichaete and Vnd binding
sites, no effects were seen when both proteins were expressed
in cells with a reporter driven by the ind enhancer (data not
shown). Thus, Vnd’s capacity to activate is dependent on both
the availability of co-factors and the DNA target. In the con-
text of the vnd enhancer, Vnd’s interaction with Dichaete
changes both the context of these proteins and also that
of the target DNA. As an HMG protein, Dichaete’s trans-
criptional co-activator ability is associated with its capacity
to bend DNA to align non-contiguous sites for interaction with
other transcription regulators [(20–22) and Figure 7]. The
capacity of Dichaete to modulate target DNA architecture
so that the contact DNA is altered potentially generates a
new dimension to NKx2.2/Vnd regulation. To address the
possibility that NKx2.2 regulates neural tube patterning by
activating transcription, Muhr et al. (1) over-expressed the
NKx2.2 homeodomain in frame with the VP16 activation
domain in the chick neural tube. This substitution did not
affect patterning of the neural tube, whereas over-
expression of the NKx2.2 homeodomain fused to the
Engrailed repression domain did. Consequently, Muhr et al.
(1) concluded that NKx2.2’s capacity to activate gene expres-
sion was not important in ventral neural tube patterning. How-
ever, these experiments modiﬁed the NKx2.2 protein but not
its target DNA. Sox 1, 2 and 3, the vertebrate homologues of
Dichaete, are expressed in overlapping patterns in the devel-
oping neural tube and Sox 2 function is necessary, but not
sufﬁcient, to direct cells to a neural fate (31,32). If Nkx2.2
interacts with one, or all, of these proteins in the neural tube,
this interaction could potentially confer transcriptional activa-
tion capacity on NKx2.2, by both reorganizing the target DNA
and directly interacting with this transcription factor. This
possibility has not yet been addressed. Interestingly, Watada
et al. (17) also identiﬁed an activation domain at the
C-terminal end of NKx2.2 that could be used in the presence
of the appropriate transcriptional co-activators to activate
target gene expression.
The intrinsic activity of Vnd’s activation domains is sup-
pressed in transient transfection assays in the context of the
full-length protein, or when full-length Vnd is fused to Gal4.
Both activation domains that we identiﬁed are predicted to
have subdomains that are helical and enriched in homopoly-
meric alanine residues interspersed with bulky amino acids.
The structure of the activation domain is as important as the
amino acid sequence to its function (33,34). Further work will
be required to deﬁne the limits of these activation domains and
the critical amino acids involved.
We were surprised to ﬁnd that a domain with no homology
to the published regulatory domains at the N-terminus of Vnd
had the strongest repression activity in our domain swap
experiments. This region is moderately conserved between
Drosophila virilis, Drosophila pseudoobscura and Drosophila
melanogaster (Z. Yu and D.M. Mellerick, unpublished data).
However, the amino acid composition is not striking. One
possibility is that the N-terminal extension of Vnd, lacking
in vertebrate Vnd-type proteins, reﬂects greater functional
complexity relative to the vertebrate counterparts. The altern-
ative possibility that this domain is not functionally signiﬁcant
in the developing Drosophila embryo cannot be excluded at
this time. Although, full-length Vnd co-precipitates with
Groucho, a Vnd deletion lacking the N-terminal 200 amino
acids, including the homeodomain and the Nk-2 box, failed to
do so (Figures 5 and 6). Potentially, this explains why we were
unable to assign repressor activity to the EH domain in the
Gal4–Vnd chimera dissection analyses (Figures 1 and 2).
It should be kept in mind that how a transcription factor
functionsinatransienttransfectionassaydoesnotalways fully
reﬂect its function in the context of the developing embryo,
where the availability of co-activators, repressors and targets
may be different. Tolkunova et al. (35) previously found that
Engrailed uses two mechanisms to repress transcription—one
that is predominant under normal transient transfection assay
conditions, the other, which is predominant in an in vivo
repression assay. The EH domain had only weak activity in
transient transfection assays, despite the fact that this
Engrailed domain mediates the in vivo repression activity
and interacts speciﬁcally with Groucho, whereas two
additional repression domains were more potent in transient
transfections than in vivo. Koizumi et al. (36) recently
found that over-expression of mutant Vnd lacking either the
NK-2 box or the NK domain in transgenic embryos did not
affect the early repression activity of the vnd transgene. Since
both these domains are highly conserved, and associated with
the repressor activity of the protein, these results were unex-
pected. One possible explanation for Koizumi’s result is that
deleting repression domains does not alter the activation
capacity of Vnd. The mutant transgenes may be able to auto-
activateexpression ofthe endogenousvndgene, resultinginits
over-expression. Consequently, the effects of the mutations
would be hidden by the over-expression of the endogenous
gene. Determining whether the mutant vnd transgenes can
rescue loss-of-function, vnd mutants will address this possib-
ility. Thus, both tissue culture and transgenic vnd over-
expression experiments have limitations in terms of their
capacity to assign a speciﬁc function to an individual domain.
Both these approaches highlight the context-dependence of
Vnd activity.
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